Eris Lifesciences Limited (ERIS.NS)
Eris Lifesciences Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ahmedabad, GU, IN. The stock last traded at $1358.50, down 1.58% on the session, giving a market capitalisation of $188.26B. Its beta of -0.04 implies it has historically moved less than the broad market.
Eris Lifesciences Limited is an Indian pharmaceutical company engaged in the manufacturing, marketing, and distribution of medicinal products throughout the country. The company provides a comprehensive range of branded formulations, catering to a wide spectrum of therapeutic areas. These encompass cardiovascular health, anti-diabetic treatments, anti-infectives, antipyretics, vitamin/nutrient supplements, gastroenterology, respiratory care, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, alongside services in in-vitro fertilization, cosmetology, and dermatology. Founded in 2007, Eris Lifesciences Limited is headquartered in Ahmedabad, India.
Eris Lifesciences Limited is most often compared with the following Healthcare names: